Thrombolytic therapy for stroke in patients with preexisting cognitive impairment
One patient out of 4 who receive thrombolytic therapy for stroke is over 80 years of age, and the proportion with cognitive decline in this age category is high. This article shows that the safety profile of thrombolytic therapy is good in the presence of cognitive decline. Ischemic stroke patients with preexisting cognitive impairment should receive recombinant tissue plasminogen activator if eligible.
See p. 2048; Editorial, p. 2044
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
Three hundred forty-seven participants from the CHARTER cohort were neurocognitively normal or had asymptomatic neurocognitive impairment (ANI) at baseline. Neurocognitive assessments occurred approximately every 6 months. ANI conveyed a 2-fold to 6-fold increase in risk …
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.